Panbela Therapeutics, Inc. (PBLA)

Panbela Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Sep 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	0.14	2.58	1.29	11.87	9.02	2.45
Short-Term Investments	4.59	-	-	-	-	-
Cash & Short-Term Investments	4.73	2.58	1.29	11.87	9.02	2.45
Cash Growth	421.17%	100.62%	-89.17%	31.53%	268.39%	74.31%
Other Receivables	0.33	0.18	0.05	0.32	0.32	0.36
Receivables	0.33	0.18	0.05	0.32	0.32	0.36
Prepaid Expenses	0.11	0.3	0.44	0.09	0.41	0.28
Total Current Assets	5.17	3.06	1.78	12.28	9.76	3.09
Other Long-Term Assets	-	8.74	3.2	0.59	0.06	0.05
Total Assets	5.17	11.8	4.98	12.87	9.81	3.14
Accounts Payable	10.95	9.94	2.87	0.64	0.55	0.6
Accrued Expenses	5.99	1.38	3.32	2.02	0.81	0.3
Short-Term Debt	2.2	-	0.65	-	-	0.74
Current Portion of Long-Term Debt	1	1	1	-	-	0.12
Total Current Liabilities	20.14	12.32	7.83	2.66	1.37	1.76
Long-Term Debt	3.19	4.19	5.19	-	-	-
Total Liabilities	23.34	16.51	13.03	2.66	1.37	1.76
Common Stock	0.01	-	-	-	0.01	0.01
Additional Paid-In Capital	128.22	120.04	82.29	66.24	54.85	42.33
Retained Earnings	-146.94	-125.5	-91.09	-56.16	-46.03	-41.26
Treasury Stock	-0	-0	-	-	-	-
Comprehensive Income & Other	0.54	0.75	0.76	0.13	-0.38	0.31
Shareholders' Equity	-18.17	-4.71	-8.05	10.21	8.45	1.39
Total Liabilities & Equity	5.17	11.8	4.98	12.87	9.81	3.14
Total Debt	6.39	5.19	6.84	-	-	0.86
Net Cash (Debt)	-1.67	-2.62	-5.56	11.87	9.02	1.59
Net Cash Growth	-	-	-	31.53%	467.06%	50.81%
Net Cash Per Share	-0.51	-24.07	-	-	-	-
Filing Date Shares Outstanding	4.85	4.85	0.02	-	-	-
Total Common Shares Outstanding	4.85	0.48	-	-	-	-
Working Capital	-14.97	-9.26	-6.06	9.62	8.39	1.33
Book Value Per Share	-3.74	-9.81	-	-	-	-
Tangible Book Value	-18.17	-4.71	-8.05	10.21	8.45	1.39
Tangible Book Value Per Share	-3.74	-9.81	-	-	-	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.